LAMA

With US$33.2 billion spent on R&D in 2003 by U.S. drug companies alone, the number of drugs reaching the market is strikingly small. This is not surprising, since current 'out-of-the-box' target identification techniques make verification prohibitively long and costly. LAMA is a scientific consultancy providing customised data analysis and management solutions in drug discovery and disease treatment strategy development for high-throughput bioarray technologies in acadmeia, medical research and industry. Our innovative Gene Links Search Engine technology accelerates delivery of high-quality drug targets at lower identification and validation costs.